Related Experiment Video

Updated: May 8, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis

C Wang1, Y Li1, H Zhang1

  • 1Department of Cell Biology, Key Laboratory of Cell Biology, Ministry of Public Health, and Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, China.

Oncogene
|August 13, 2013
PubMed

Insights

p21-activated kinase 4 (PAK4) suppresses transforming growth factor-beta (TGF-β) signaling by modulating Smad2/3 activity, promoting gastric cancer growth. PAK4 represents a potential therapeutic target for gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • p21-activated kinase 4 (PAK4) and transforming growth factor-beta (TGF-β) signaling effectors Smad2/3 are altered in various tumors.
  • The interplay between PAK4 and Smad2/3 in tumorigenesis remains unexplored.

Purpose of the Study:

  • To investigate the relationship between PAK4 and Smad2/3 signaling in gastric cancer.
  • To elucidate the mechanisms by which PAK4 influences Smad2/3 activity and TGF-β-mediated growth inhibition.

Main Methods:

  • Co-immunoprecipitation assays to detect PAK4-Smad2/3 interaction.
  • Western blotting to analyze protein phosphorylation and degradation.
  • Analysis of patient tumor tissues to correlate protein expression levels.

Main Results:

  • PAK4 interacts with Smad2/3, inhibiting TGF-β1-induced phosphorylation and activation via kinase-dependent and -independent pathways.
  • PAK4 promotes Smad2 degradation under hepatocyte growth factor (HGF) stimulation.
  • PAK4 expression correlates with altered Smad2 phosphorylation and decreased Smad2 levels in gastric cancer tissues.

Conclusions:

  • PAK4 acts as an oncogenic factor in gastric cancer by repressing Smad2/3 transactivation.
  • PAK4 is a potential therapeutic target for gastric cancer treatment.

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...